Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

BTNL2 helps protect hair follicles from immune attacks.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

The hair disorder was caused by abnormal protein formation, making hair easily damaged.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Adrenal tumors should be considered in Addison's disease if unusual results appear, with surgery as a solution.

Two patients with Cronkhite-Canada syndrome achieved remission after treatment.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

A rare case links early-onset alopecia universalis and nephrotic syndrome, suggesting genetic immune issues.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Congenital adrenal hyperplasia may be linked to adrenal myelolipoma.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Thymectomy and high-dose prednisolone improved hair loss in a woman with alopecia areata.

Pityriasis rubra pilaris can occur with myasthenia gravis.

The boy's hair and skin color differences are due to a pigmentation disorder.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Lgr6+ cells are important for tissue repair and could be a target for treating cancer and other diseases.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.